Filter the drugs by their COVID-19 status, phase of research and how they help

COVID-19 is a respiratory disease caused by the SARS-CoV-2 virus. Browse the database of potential drugs for COVID-19 treatment compiled by the AIM tool.
Substance
COVID-19 status
Phase of research
How it helps
Latest publication
Supporting references
Contradictory references
W4P-RBD Potential treatment - pre-clinical evidence Experimental Vaccine Feb/26/2021 1 0
Tixagevimab Emergency use authorization Experimental Antiviral Jan/04/2022 4 0
S309 Potential treatment - pre-clinical evidence Experimental Antiviral Jan/04/2022 3 0
pCMVkan-S Potential treatment - pre-clinical evidence Experimental Vaccine Mar/22/2021 1 0
mRNA-1273 Emergency use authorization Experimental Vaccine Feb/03/2022 1 0
mAb Beta-56 Potential treatment - pre-clinical evidence Experimental Antiviral Jan/04/2022 1 0
mAb Beta-55 Potential treatment - pre-clinical evidence Experimental Antiviral Jan/04/2022 1 0
mAb Beta-54 Potential treatment - pre-clinical evidence Experimental Antiviral Jan/04/2022 1 0
mAb Beta-53 Potential treatment - pre-clinical evidence Experimental Antiviral Jan/04/2022 1 0
mAb Beta-47 Potential treatment - pre-clinical evidence Experimental Antiviral Jan/04/2022 1 0